OTC Markets OTCPK - Delayed Quote USD

Assura Plc (ARSSF)

Compare
0.6200
-0.0200
(-3.12%)
At close: April 3 at 4:00:00 PM EDT
Loading Chart for ARSSF
  • Previous Close 0.6400
  • Open 0.6400
  • Bid 0.5841 x 308300
  • Ask 0.6495 x 306000
  • Day's Range 0.6400 - 0.6400
  • 52 Week Range 0.4320 - 0.6400
  • Volume 5,000
  • Avg. Volume 438
  • Market Cap (intraday) 2.015B
  • Beta (5Y Monthly) 0.56
  • PE Ratio (TTM) 20.67
  • EPS (TTM) 0.0300
  • Earnings Date May 19, 2025 - May 23, 2025
  • Forward Dividend & Yield 0.04 (6.99%)
  • Ex-Dividend Date Mar 6, 2025
  • 1y Target Est --

Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served. A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders. At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

www.assuraplc.com

84

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ARSSF

View More

Performance Overview: ARSSF

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

ARSSF
26.27%
FTSE 100 (^FTSE)
0.33%

1-Year Return

ARSSF
24.91%
FTSE 100 (^FTSE)
2.13%

3-Year Return

ARSSF
17.30%
FTSE 100 (^FTSE)
7.77%

5-Year Return

ARSSF
41.95%
FTSE 100 (^FTSE)
50.42%

Compare To: ARSSF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ARSSF

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    2.00B

  • Enterprise Value

    4.06B

  • Trailing P/E

    22.83

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.81

  • Price/Book (mrq)

    0.97

  • Enterprise Value/Revenue

    18.92

  • Enterprise Value/EBITDA

    32.03

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    40.21%

  • Return on Assets (ttm)

    2.74%

  • Return on Equity (ttm)

    4.23%

  • Revenue (ttm)

    164.4M

  • Net Income Avi to Common (ttm)

    66.1M

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.2M

  • Total Debt/Equity (mrq)

    100.10%

  • Levered Free Cash Flow (ttm)

    15.39M

Research Analysis: ARSSF

View More

Company Insights: ARSSF

Research Reports: ARSSF

View More

People Also Watch